Conditions: Rheumatoid Arthritis
Keywords: NOS
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 108
Healthy volunteers: no

Brief summary:
The purpose of this exploratory sub-study was to evaluate from a clinical perspective the impact on disease activity of lowering the dose of abatacept from 10 mg/kg to 5 mg/kg in subjects who had achieved remission (Disease Activity Score 28 \[DAS 28\]-erythrocyte sedimentation rate \[ESR\] \< 2.6) at Day 701 of study IM101023.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Abatacept intervention 2: Abatacept
Intervention descriptions: intervention 1: IV solution, IV, 10 mg/Kg, Once monthly, 1 year intervention 2: IV solution, IV, 5 mg/Kg, Once monthly, 1 year

Protocol document: